Author correction to ‘Co-delivery of nigericin and decitabine using hexahistidine-metal nanocarriers for pyroptosis-induced immunotherapeutics’ [Acta Pharm Sin B 12 (2022) 4458–4471]

• Qiang Niu,
• Yu Liu,
• Yujing Zheng,
• Ziwei Tang,
• Yuna Qian,
• Ruogu Qi,
• Jianliang Shen,
• Ping Zhao

Affiliations

Qiang Niu

School of Chemistry and Chemical Engineering, Guangdong Pharmaceutical University, Guangzhou 510006, China

Yu Liu

State Key Laboratory of Ophthalmology, Optometry and Vision Science, School of Ophthalmology and Optometry, School of Biomedical Engineering, Wenzhou Medical University, Wenzhou 325027, China

Yujing Zheng

State Key Laboratory of Ophthalmology, Optometry and Vision Science, School of Ophthalmology and Optometry, School of Biomedical Engineering, Wenzhou Medical University, Wenzhou 325027, China

Ziwei Tang

School of Chemistry and Chemical Engineering, Guangdong Pharmaceutical University, Guangzhou 510006, China

Yuna Qian

State Key Laboratory of Ophthalmology, Optometry and Vision Science, School of Ophthalmology and Optometry, School of Biomedical Engineering, Wenzhou Medical University, Wenzhou 325027, China; Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou 325001, China

Ruogu Qi

School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China; Corresponding authors.

Jianliang Shen

State Key Laboratory of Ophthalmology, Optometry and Vision Science, School of Ophthalmology and Optometry, School of Biomedical Engineering, Wenzhou Medical University, Wenzhou 325027, China; Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou 325001, China; Corresponding authors.

Ping Zhao

School of Chemistry and Chemical Engineering, Guangdong Pharmaceutical University, Guangzhou 510006, China; Corresponding authors.